Page last updated: 2024-08-18

1,3-ditolylguanidine and Cancer of Pancreas

1,3-ditolylguanidine has been researched along with Cancer of Pancreas in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abate, C; Berardi, F; Hawkins, WG; Hornick, JR; Niso, M; Perrone, R; Spitzer, D1

Other Studies

1 other study(ies) available for 1,3-ditolylguanidine and Cancer of Pancreas

ArticleYear
Fluorescent derivatives of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) as a tool for uptake and cellular localization studies in pancreatic tumor cells.
    Journal of medicinal chemistry, 2011, Aug-25, Volume: 54, Issue:16

    Topics: Binding, Competitive; Cell Line, Tumor; Endocytosis; Endoplasmic Reticulum; Flow Cytometry; Fluorescence; Humans; Ligands; Lysosomes; Microscopy, Confocal; Microscopy, Fluorescence; Models, Chemical; Molecular Structure; Pancreatic Neoplasms; Piperazines; Protein Binding; Protein Isoforms; Radioligand Assay; Receptors, sigma

2011